Filing Details
- Accession Number:
- 0000899243-17-018211
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-12 16:05:31
- Reporting Period:
- 2017-06-30
- Filing Date:
- 2017-07-12
- Accepted Time:
- 2017-07-12 16:05:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1042418 | Hedgepath Pharmaceuticals Inc. | HPPI | Services-Commercial Physical & Biological Research (8731) | 541641133 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1584617 | Hedgepath, Llc | 324 S. Hyde Park Avenue, Suite 350 Tampa FL 33606 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $.0001 Par Value Per Share | Disposition | 2017-06-30 | 2,500,000 | $0.00 | 79,627,069 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- On June 30, 2017, the Reporting Person sold 2,500,000 shares of restricted common stock in a private transaction to an unaffiliated third party for a total purchase price of $500,000.
Billionaire Hedge Funds
